Urotensin-II as an angiogenic factor

Peptides

Volumn 31, Issue 6, 2010, Pages 1219-1224

  Guidolin, Diego ^a   Albertin, Giovanna ^a   Ribatti, Domenico ^b  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Angiogenesis; Antiangiogenesis; Urotensin

Indexed keywords

UROTENSIN; UROTENSIN II;

ANGIOGENESIS; CAPILLARY; GROWTH REGULATION; HEMODYNAMICS; HUMAN; MICROVASCULATURE; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TISSUE STRUCTURE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; UROTENSINS;

RODENTIA;

EID: 77952110710     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.03.022     Document Type: Review

References (81)

1. Albertin G., Guidolin D., Sorato E., Spinazzi R., Mascarin A., Oselladore B., et al. Pro-angiogenic activity of Urotensin-II on different human vascular endothelial cell populations. Regul Pept 157 (2009) 64-71
2. Ames R.S., Sarau H.M., Chambers J.K., Willette R.N., Aiyar N.V., Romanic A.M., et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401 (1999) 282-286
3. Arnaoutova I., George J., Kleinman H.K., and Benton G. The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis 12 (2009) 267-274
4. Behm D.J., Harrison S.M., Ao Z., Maniscalco K., Pickering S.J., Grau E.V., et al. Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice. Br J Pharmacol 139 (2003) 464-472
5. Birker-Robaczewska M., Boukhandra C., Studer R., Mueller C., Binkert C., and Nayler O. The expression of urotensin II receptor (U2R) is up regulated by interferon-γ. J Recept Signal Transduct Res 23 (2003) 289-305
6. Bottrill F.E., Douglas S.A., Hiley C.R., and White R. Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. Br J Pharmacol 130 (2000) 1865-1870
7. Bousette N., Patel L., Douglas S.A., Ohlstein E.H., and Giaid A. Increased expression of urotensin-II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta. Atherosclerosis 176 (2004) 117-123
8. Brailoiu E., Jiang X., Brailoiu G.C., Yang J., Chang J.K., Wang H., et al. State-dependent calcium mobilization by urotensin-II in cultured human endothelial cells. Peptides 29 (2008) 721-726
9. Chen Y., Zhao M., Liu X., Yao W., Yang J., Zhang Z., et al. Urotensin II receptor in the rat airway smooth muscle and its effect on the rat airway smooth muscle cells proliferation. Chin Med Sci J 16 (2001) 231-235
10. Chen Y.H., Zhao M.W., Yao W.Z., Pang Y.Z., and Tang C.S. The signal transduction pathway in the proliferation of airway smooth muscle cells induced by urotensin II. Chin Med J (Engl) 117 (2004) 37-41
11. Chen Y.H., Yandle T.G., Richards A.M., and Palmer S.C. Urotensin II immunoreactivity in the human circulation: evidence for widespread tissue release. Clin Chem 55 (2009) 2040-2048
12. Cirillo P., De Rosa S., Pacileo M., Gargiulo A., Angri V., Fiorentino I., et al. Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease. J Thromb Haemost 6 (2008) 726-736
13. Clozel M., Binkert C., Birker-Robaczewska M., Boukhadra C., Ding S.S., Fischli W., et al. Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin system. J Pharmacol Exp Ther 311 (2004) 204-212
14. Coulouarn Y., Jegou S., Tostivint H., Vaudry H., and Lihrmann I. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 457 (1999) 28-32
15. Davenport A.P., and Maguire J.J. Urotensin II: fish neuropeptide catches orphan receptor. Trends Pharmacol Sci 21 (2000) 80-92
16. Djonov V., and Makanya A.N. New insights into intussusceptive angiogenesis. In: Clauss M., and Breier G. (Eds). Mechanisms of angiogenesis (2005), Birkhäuser Verlag, Bern 17-33
17. Douglas S.A., and Ohlstein E.H. Urotensin receptors. In: Girdlestone D. (Ed). The IUPHAR compendium of receptor characterization and classification (2000), IUPHAR Media, London 365-372
18. Douglas S.A., Tayara L., Ohlstein E.H., Halawa N., and Giaid A. Congestive heart failure and expression of myocardial urotensin II. Lancet 359 (2002) 1990-1997
19. Douglas S.A., Naselsky D., Ao Z., Disa J., Herold C.L., Lynch F., et al. Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines. Br J Pharmacol 142 (2004) 921-932
20. Dutt P., Kjoller L., Giel M., Hall A., and Toksoz D. Activated Galphaq family members induce Rho GTPase activation and Rho-dependent actin filament assembly. FEBS Lett 531 (2002) 565-569
21. Gendron G., Simard B., Gobeil F., Sirois P., D'Orleans-Juste P., and Regoli D. Human urotensin-II enhance extravasation in specific vascular districts in Wistar rats. Can J Physiol Pharmacol 82 (2004) 16-21
22. Giebing G., Tölle M., Jürgensen J., Eichhorst J., Furkert J., Beyermann M., et al. Arrestin-independent internalization and recycling of the urotensin receptor contribute to long-lasting urotensin II-mediated vasoconstriction. Circ Res 97 (2005) 707-715
23. Gohla A., Harhammer R., and Schultz G. The G-protein G13 but not G12 mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to Rho. J Biol Chem 273 (1998) 4653-4659
24. Gong H., Wang Y.-X., Zhu Y.-Z., Wang W.-W., Wang M.-J., Yao T., et al. Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat. J Appl Physiol 97 (2004) 2228-2235
25. Gray G.A., Jones M.R., and Sharif I. Human urotensin II increases coronary perfusion pressure in the isolated rat heart: potentiation by nitric oxide synthase and cyclooxygenase inhibition. Life Sci 69 (2001) 175-180
26. Guidolin D, Albertin G, Oselladore B, Sorato E, Rebuffat P, Mascarin A et al. The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways. Regul Pept, 2010, doi:10.1016/j.regpep.2010.02.009.
27. Gutkind J.S., and Offermanns S. A new Gq-initiated MAPK signaling pathway in the heart. Dev Cell 16 (2009) 163-164
28. Hassan G.S., Douglas S.A., Ohlstein E.H., and Giaid A. Expression of urotensin-II in human coronary atherosclerosis. Peptides 26 (2005) 2464-2472
29. Heil M., and Schaper W. Cellular mechanisms of arteriogenesis. In: Clauss M., and Breier G. (Eds). Mechanisms of angiogenesis (2005), Birkhäuser Verlag, Bern 181-191
30. Heil M., Eitenmüller I., Schmitz-Rixen T., and Schaper W. Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med 10 (2006) 45-55
31. Heringlake M., Kox T., Uzun O., Will B., Bahlmann L., Klaus S., et al. The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease. Regul Pept 121 (2004) 129-136
32. Itoh H., McMaster D., and Lederis K. Functional receptors for fish neuropeptide urotensin II in major rat arteries. Eur J Pharmacol 149 (1988) 61-66
33. Lang I., Schweizer A., Hiden U., Ghaffari-Tabrizi N., Hagendorfer G., Bilban M., et al. Human fetal placental endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potential. Differentiation 76 (2008) 1031-1043
34. Liu Q., Pong S.S., Zeng Z., Zhang Q., Howard A.D., Williams Jr. D.L., et al. Identification of urotensin II as the endogenous ligand for the orphan G-protein coupled receptor GPR14. Biochem Biophys Res Commun 266 (1999) 174-178
35. Liu Z.-M., Chen G.G., Vlantis A.C., Tse G.M., Shum C.K.Y., and van Hasselt C.A. Calcium-mediated activation of PI3K and p53 leads to apoptosis in thyroid carcinoma cells. Cell Mol Life Sci 64 (2007) 1428-1436
36. Loirand G., Rolli-Derkinderen M., and Pacaud P. Urotensin II and atherosclerosis. Peptides 29 (2008) 778-782
37. Lorenz K., Schmitt J.P., Schmitteckert E.M., and Lohse M.J. A new type of ERK1/2 autophosphorilation causes cardiac hypertrophy. Nat Med 15 (2009) 75-83
38. Maguire J.J., Kuc R.E., and Davenport A.P. Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 131 (2000) 441-446
39. Maguire J.J., and Davenport A.P. Is urotensin-II the new endothelin?. Br J Pharmacol 137 (2002) 579-588
40. Maguire J.J., Kuc R.E., Wiley K.E., Kleinz M.J., and Davenport A.P. Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries. Peptides 25 (2004) 1767-1774
41. Maguire J.J., Kuc R.E., Kleinz M.J., and Davenport A.P. Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: relevance to function. Peptides 29 (2008) 735-742
42. Malagon M.M., Molina M., Gahete M.D., Duran-Prado M., Martinez-Fuente A.J., Alcain F.J., et al. Urotensin II and urotensin II-related peptide activate somatostatin receptor subtypes 2 and 5. Peptides 29 (2008) 711-720
43. Marinissen M.J., and Gutkind J.S. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22 (2001) 368-376
44. Matsusaka S., and Wakabayashi I. Enhancement of vascular smooth muscle cell migration by urotensin II. Naunyn Schmiedeberg's Arch Pharmacol 373 (2006) 381-386
45. Matsushita M., Shichiri M., Imai T., Iwashina M., Tanaka H., Takasu N., et al. Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 19 (2001) 2185-2190
46. Matsushita M., Shichiri M., Fukai N., Ozawa N., Yoshimoto T., Takasu N., et al. Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line, LLCPK1. Endocrinology 144 (2003) 1825-1831
47. New D.C., and Wong Y.H. Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression. J Mol Signal 2 (2007) 2
48. Onan D., Hannan R.D., and Thomas W.G. Urotensin-II: the old kid in town. Trends Endocrinol Metab 15 (2004) 175-182
49. Onan D., Pipolo L., Yang E., Hannan R.D., and Thomas W.G. Urotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinases. Mol Endocrinol 18 (2004) 2344-2354
50. Papadopoulos P., Bousette N., and Giaid A. Urotensin-II and cardiovascular remodeling. Peptides 29 (2008) 764-769
51. Papadopoulos P., Bousette N., Al-Ramli W., You Z., Behm D.J., Ohlstein E.H., et al. Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with western diet. Atherosclerosis 204 (2009) 395-404
52. Peng X., Yin H., Wang L.H., Chai S.B., Shu J.L., and Tang C.S. Content and activity of the focal adhesion kinase in cultured vascular smooth muscle cells enhanced by urotensin II. Sheng Li Xue Bao 52 (2000) 455-458
53. Proulx C.D., Holleran B.J., Lavigne P., Escher E., Guillemette G., and Leduc R. Biological properties and functional determinants of the urotensin-II receptor. Peptides 29 (2008) 691-699
54. Rakowski E., Hassan G.S., Dhanak D., Ohlstein E.H., Douglas S.A., and Giaid A. A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blocker. J Mol Cell Cardiol 39 (2005) 785-791
55. Ribatti D., Conconi M.T., and Nussdorfer G.G. Nonclassic endogenous regulators of angiogenesis. Pharmacol Rev 59 (2007) 185-205
56. Ribatti D., Nico B., Crivellato E., Roccaro A.M., and Vacca A. The history of the angiogenic switch concept. Leukemia 21 (2007) 44-52
57. Richards A.M., and Charles C. Urotensin II in the cardiovascular system. Peptides 25 (2004) 1795-1802
58. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
59. Russell F.D., Molenaar P., and O'Brien D.M. Cardiostimulant effects of urotensin-II in human heart in vitro. Br J Pharmacol 132 (2001) 5-9
60. Russell F.D., Meyers D., galbraith A.J., Bett N., Toth I., Kearns P., et al. Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. Am J Physiol Heart Circ Physiol 285 (2003) 1576-1581
61. Saetrum Opgaard O., Nothacker H., Ehlert F.J., and Krause D.N. Human urotensin II mediates vasoconstriction via an increase in inositol phosphates. Eur J Pharmacol 406 (2000) 265-271
62. Sauzeau V., Le Mellionec E., Bertoglio J., Scalbert E., Pacaud P., and Loirand G. Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ Res 88 (2001) 1102-1104
63. Scheel K.W., Fitzgerald E.M., Martin R.O., and Larsen R.A. The possible role of mechanical stresses on coronary collateral development during gradual coronary occlusion. In: Schaper W. (Ed). The pathophysiology of myocardial perfusion (1979), Elsevier/North-Holland, Amsterdam 489-518
64. Segain J.P., Rolli-Derkinderen M., Gervois N., Raingeard de la Blètière D., Loirand G., and Pacaud P. Urotensin II is a new chemotactic factor for UT receptor-expressing monocytes. J Immunol 179 (2007) 901-909
65. Shi X.-D., Li Z.-L., Wu H.-C., Wang T.-H., Fu Q., Yan Q.-N., et al. Mechanism of urotensin II-stimulated adrenomedullin secretion in human vascular endothelial cells. Di Yi Jun Yi Da Xue Xue Bao 25 (2005) 791-793
66. Shi L., Ding W., Li D., Wang Z., Jiang H., Zhang J., et al. Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells. Atherosclerosis 188 (2006) 260-264
67. Spinazzi R., Albertin G., Nico B., Guidolin D., Di Liddo R., Rossi G.P., et al. Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro. Int J Mol Med 18 (2006) 1107-1112
68. Staton C.A., Stribbling S.M., Tazzyman S., Hughes R., Brown N.J., and Lewis C.E. Current methods for assaying angiogenesis in vitro and in vivo. Int J Exp Pathol 85 5 (2004) 233-248
69. Tian L., Li C., Qi J., Fu P., Yu X., Li X., et al. Diabetes-induced upregulation of urotensin-II and its receptor plays an important role in TGF-β1-mediated renal fibrosis and dysfunction. Am J Physiol Endocrinol Metab 295 (2008) E1234-E1242
70. Tsai C.-S., Loh S.-H., Liu J.-C., Lin J.-W., Chen Y.-L., Chen C.-H., et al. Urotensin II-induced endothelin-1 expression and cell proliferation via epidermal growth factor receptor transactivation in rat aortic smooth muscle cells. Atherosclerosis 206 (2009) 86-94
71. Tzanidis A., Hannan R.D., Thomas W.G., Onan D., Autelitano D.J., See F., et al. Direct actions of urotensin II on the heart. Implications for cardiac fibrosis and hypertrophy. Circ Res 93 (2003) 246-253
72. Wang H., Mehta J.L., Chen K., Zhang X., and Li D. Human urotensin II modulates collagen synthesis and the expression of MMP-1 in human endothelial cells. J Cardiovasc Pharmacol 44 (2004) 577-581
73. Watanabe T., Pakala R., Katagiri T., and Benedict C.R. Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 104 (2001) 16-18
74. Watanabe T., Suguro T., Kanome T., Sakamoto Y., Kodate S., Hagiwara T., et al. Human urotensin II accelerates foam cell formation in human monocyte derived macrophages. Hypertension 46 (2005) 738-744
75. Watanabe T., Takahashi K., Kanome T., Hongo S., Miyazaki A., Koba S., et al. Human uritensin-II potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells: comparison with other vasoactive agents and hydrogen peroxide. Hypertens Res 29 (2006) 821-831
76. Watanabe T., Arita S., Shiraishi Y., Suguro T., Sakai T., Hongo S., et al. Human urotensin II promotes hypertension and atherosclerotic cardiovascular diseases. Curr Med Chem 16 (2009) 550-563
77. Xu S., Jiang H., Wu B., Yang J., and Chen S. Urotensin II induces migration of endothelial progenitor cells via activation of the RhoA/Rho kinase pathway. Tohoku J Exp Med 219 (2009) 283-288
78. Yoshimoto T., Matsushita M., and Hirata Y. Role of urotensin II in periferal tissues as an autocrine/paracrine growth factor. Peptides 25 (2004) 1775-1781
79. Zhang Y.M., Liu W.J., Shi Y.Z., Gao Y.F., Wang L.L., and Cheng M.X. Expressions of urotensin II and its receptor in pulmonary arteries in rats with chronic thromboembolic pulmonary hypertension. Zhonghua Jie He He Hu Xi Za Zhi 31 (2008) 37-41
80. Zhang Y., Fisher N., Newey S.E., Smythe J., Tatton L., Tsaknakis G., et al. The impact of proliferative potential of umbilical cord-derived endothelial progenitor cells and hypoxia on vascular tubule formation in vitro. Stem Cells Dev 18 (2009) 359-375
81. Ziltener P., Mueller C., Haenig B., Scherz M.W., and Nayler O. Urotensin II mediates ERK1/2 phosphorilation and proliferation in GPCR14-transfected cell lines. J Recept Signal Trans Res 22 (2002) 155-168